[Osteoprotection in patients with non-metastatic hormone-sensitive prostate cancer (mHSPC) receiving androgen-deprivation therapy (ADT): Real-world data from Germany, presented by d-uo].
Aktuelle Urologie(2022)
关键词
Denosumab,bone mineral density,osteoprotection,prostate cancer,bisphosphonate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要